Michael Henderson

Chief Executive Officer at APOGEE THERAPEUTICS, INC.

Net worth: 97 M $ as of 2026-05-30

36 year

22 connections

Health Technology

Consumer Services

Commercial Services

Profile

Michael Henderson founded PellePharm, Inc. He is Chief Executive Officer for QED Therapeutics, Inc., Chief Executive Officer at Origin Biosciences, Inc. and Chief Business Officer for BridgeBio Pharma, Inc. and on the board of 5 other companies. In the past he held the position of Senior Associate at McKinsey & Co., Inc. Dr. Henderson received an undergraduate degree from Harvard University and a doctorate from Stanford University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
APOGEE THERAPEUTICS, INC. 1.96%	2026-06-09	1,095,987 ( 1.96% )	90 M $	2026-05-30
SPYRE THERAPEUTICS, INC 0.1%	2026-05-26	88,606 ( 0.1% )	7 M $	2026-05-30

Latest news about Michael Henderson

24-09-12

SpaceX-Polaris crew make first private spacewalk

Michael Henderson active positions

Companies	Position	Start
SPYRE THERAPEUTICS, INC.	Director/Board Member	2023-06-21
APOGEE THERAPEUTICS, INC.	Chief Executive Officer	2022-08-31
QED Therapeutics, Inc. QED Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals	Chief Executive Officer	-
Origin Biosciences, Inc. Origin Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals	Chief Executive Officer	-
Therasis, Inc. Therasis, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology drugs	Director/Board Member	2016-08-31
Adrenas Therapeutics, Inc.	Director/Board Member	2017-06-30
Quartz Therapeutics, Inc.	Director/Board Member	2016-08-31

All active positions of Michael Henderson

Former positions of Michael Henderson

Companies	Position	End
ARYA SCIE	Director/Board Member	2024-07-31
BRIDGEBIO PHARMA, INC.	Corporate Officer/Principal	2022-08-31
░░░░░░░░ ░░░░░ ░░░░ ░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░
░░░░░░░░░░░ ░░░░	░░░░░░░	-

See the detail of Michael Henderson's experience

Training of Michael Henderson

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michael Henderson's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	13
Spyre Therapeutics, Inc. Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company	Health Technology
PellePharm, Inc. PellePharm, Inc. BiotechnologyHealth Technology Develops biotechnologies to cure dermatological diseases	Health Technology
McKinsey & Co., Inc. McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm	Commercial Services
Harvard University Harvard University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Stanford University Stanford University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Therasis, Inc. Therasis, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology drugs	Health Technology
QED Therapeutics, Inc. QED Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals	Health Technology
Origin Biosciences, Inc. Origin Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals	Health Technology
BridgeBio Pharma, Inc. BridgeBio Pharma, Inc. BiotechnologyHealth Technology Develops medicines for genetic diseases to patients	Health Technology
Quartz Therapeutics, Inc.
Adrenas Therapeutics, Inc.
ARYA Sciences Acquisition Corp. IV ARYA Sciences Acquisition Corp. IV Financial ConglomeratesFinance Operates as a blank check company	Finance
Apogee Therapeutics, Inc. Apogee Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops therapies for immunological and inflammatory disorders	Health Technology